IP Library Granted Patent US 10,058,679
Granted Patent B2
US 10,058,679 · App. 15/097,110 · Granted Aug 28, 2018

Assemblies, systems, and methods for infusing therapeutic agents into the body

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,058,679
App. No.
15/097,110
Granted
Aug 28, 2018
Kind
B2
Abstract

An infusion catheter assembly has the ability to infinitely titrate the length of a porous fluid distribution section in situ. The infusion catheter assembly thereby provides a length of infusion that can be infinitely varied over a prescribed range, to control the effective infusion length and the rate of infusion. Using the infusion catheter assembly, a physician has the capability to treat only the length of the vessel desired, thereby preventing excessive drug/patient exposures. The porous fluid distribution section can include an array of spaced apart apertures that vary in size and/or density along the length of the porous fluid distribution section, such that the flow rate remains essentially constant for a given inlet pressure independent of the effective infusion length.

Claims (15)

1. An infusion method comprising:

(i) providing an outer catheter body having an interior lumen and including a porous fluid distribution section having a predefined maximum length communicating with the interior lumen;

(ii) inserting into the outer catheter body an inner catheter body having at least one fluid delivery port for dispensing a fluid from an external source into communication with the porous fluid distribution section for infusion through the porous fluid distribution section, the inner catheter body including a barrier structure proximal of the fluid delivery port, the barrier structure having a reduced dimension condition and an increased dimension condition;

(iii) manipulating the inner catheter body by sliding the inner catheter body within the outer catheter body when the barrier structure is in a reduced dimension condition along the maximum length of the porous fluid distribution section;

(iv) manipulating the inner catheter body by placing the barrier structure in an increased dimension condition to press the barrier structure against the interior lumen and form a barrier wall that blocks flow of the dispensed fluid into communication with the porous fluid distribution section proximal of the barrier wall;

(v) performing (iii) and (iv) to selectively reduce and increase the dimension of the barrier structure within the outer catheter body along the maximum length of the porous fluid distribution section to establish for the infusion catheter assembly a desired effective infusion length, wherein the desired effective infusion length is infinitely variable between the maximum length and any smaller length along the porous fluid distribution section; and

(vi) infusing a fluid through the desired effective infusion length of the porous fluid distribution section.

2. The infusion method according to claim 1 , wherein (v) includes visualizing the effective infusion length by radiographic imagining of an outer radiopaque marker on the outer catheter body and an inner radiopaque marker on the inner catheter body.

3. The infusion method according to claim 1 , wherein (v) includes using a guide wire.

4. The infusion method according to claim 1 , wherein (vi) is performed in a blood vessel.

5. The infusion method according to claim 1 , wherein (vi) is performed in a tissue mass or organ.

6. The infusion method according to claim 1 , wherein (vi) includes delivery of a therapeutic agent.

7. The infusion method according to claim 1 , wherein (vi) includes delivery of anesthesia.

8. The infusion method according to claim 1 , wherein (vi) includes treatment of an occlusion or thrombus in the vasculature.

9. The infusion method according to claim 1 , wherein (vi) includes treatment of a tumor.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 062437 FRAME: 0600. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 9, 2024
From: VENOUS THERAPY INC.
To: VENOUS THERAPY INC.
Reel/Frame 066241/0689 →
CHANGE OF OWNER/ASSIGNEE ADDRESS Recorded Jan 19, 2023
From: ARGON MEDICAL DEVICES, INC.
To: ARGON MEDICAL DEVICES, INC.
Reel/Frame 062437/0600 →
CORRECTIVE ASSIGNMENT TO CORRECT THE THE RECEIVING PARTY NAME "VENOUS THERAPY, INC." TO "VENOUS THERAPY INC. PREVIOUSLY RECORDED AT REEL: 041668 FRAME: 0986. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 16, 2020
From: COMEROTA, ANTHONY J; FOGARTY, THOMAS J; OLSON, JONATHAN M; LOTTI, RICHARD A
To: VENOUS THERAPY INC.
Reel/Frame 051620/0574 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2017
From: COMEROTA, ANTHONY J.; FOGARTY, THOMAS J.; OLSON, JONATHAN M.; LOTTI, RICHARD A.
To: VENOUS THERAPY, INC.
Reel/Frame 041668/0986 →